Travere Therapeutics, Inc. — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B3
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002431 | Mar 27, 2026 | — |
| 4 | — | 0001283303-26-000006 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001950047-26-002635 | Mar 16, 2026 | — |
| 4 | — | 0001763494-26-000003 | Feb 24, 2026 | Feb 20, 2026 |
| 144 | — | 0001959173-26-001307 | Feb 20, 2026 | — |
| 10-K | 10-K | 0001438533-26-000014 | Feb 19, 2026 | Dec 31, 2025 |
| 4 | — | 0001283303-26-000005 | Feb 19, 2026 | Feb 17, 2026 |
| 8-K | 8-K | 0001438533-26-000013 | Feb 19, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-001227 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001339 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-054520 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-049707 | Feb 13, 2026 | — |
| 4 | — | 0001902368-26-000004 | Feb 5, 2026 | Feb 4, 2026 |
| 4 | — | 0001943192-26-000002 | Feb 5, 2026 | Feb 4, 2026 |
| 4 | — | 0001283303-26-000003 | Feb 5, 2026 | Feb 4, 2026 |
| 144 | — | 0001950047-26-000918 | Feb 4, 2026 | — |
| 144 | — | 0001950047-26-000917 | Feb 4, 2026 | — |
| 144 | — | 0001950047-26-000904 | Feb 4, 2026 | — |
| 144 | — | 0001193125-26-036557 | Feb 4, 2026 | — |
| 144 | — | 0001193125-26-036479 | Feb 3, 2026 | — |
| 144 | — | 0001193125-26-036474 | Feb 3, 2026 | — |
| 144 | — | 0001193125-26-036459 | Feb 3, 2026 | — |
| 144 | — | 0001193125-26-036456 | Feb 3, 2026 | — |
| 4 | — | 0001763494-26-000002 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001902368-26-000003 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001943192-26-000001 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001789617-26-000001 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001698262-26-000001 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001882909-26-000001 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | — | 0001283303-26-000002 | Feb 3, 2026 | Jan 31, 2026 |
| 144 | — | 0001959173-26-000570 | Feb 3, 2026 | — |
| 144 | — | 0001959173-26-000560 | Feb 3, 2026 | — |
| 4 | — | 0001763494-26-000001 | Jan 27, 2026 | Jan 23, 2026 |
| 144 | — | 0001959173-26-000458 | Jan 27, 2026 | — |
| 144 | — | 0001959173-26-000432 | Jan 23, 2026 | — |
| 4 | — | 0001283303-26-000001 | Jan 21, 2026 | Jan 20, 2026 |
| 144 | — | 0001950047-26-000541 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001438533-26-000005 | Jan 13, 2026 | — |
| 8-K | 8-K | 0001438533-26-000003 | Jan 12, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000051 | Jan 8, 2026 | — |
| 4 | — | 0001902368-26-000002 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001950047-26-000175 | Jan 6, 2026 | — |
| 144 | — | 0001193125-26-003062 | Jan 5, 2026 | — |
| 4 | — | 0001789617-25-000009 | Dec 29, 2025 | Dec 24, 2025 |
| 4 | — | 0001698262-25-000005 | Dec 29, 2025 | Dec 24, 2025 |
| 4 | — | 0001902368-25-000005 | Dec 29, 2025 | Dec 24, 2025 |
| 4 | — | 0001882909-25-000008 | Dec 29, 2025 | Dec 24, 2025 |
| 144 | — | 0001950047-25-010715 | Dec 29, 2025 | — |
| 144 | — | 0001950047-25-010713 | Dec 29, 2025 | — |
| 144 | — | 0001959173-25-007920 | Dec 29, 2025 | — |